Skip to main content
. 2017 Jan 8;38(19):1485–1494. doi: 10.1093/eurheartj/ehw598

Table 3.

Multivariable predictors of CRT-D implantation

CRT-D All CRT-D Female CRT-D Male OR (95% CI)
OR (95% CI) OR (95% CI)
Male 1.80 (1.71–1.90) - -
Calendar Yeara 0.90 (0.88–0.93) 0.88 (0.86–0.91) 0.92 (0.89–0.94)
Age
 18–54 ref Ref ref
 55–64 0.92 (0.81–1.04) 0.99 (0.81–1.21) 0.87 (0.75–1.01)
 65–74 0.65 (0.57–0.74) 0.70 (0.57–0.86) 0.61 (0.53–0.71)
 75–84 0.39 (0.34–0.44) 0.38 (0.31–0.47) 0.38 (0.33–0.44)
 ≥85 0.12 (0.11–0.14) 0.12 (0.09–0.15) 0.12 (0.10–0.15)
Race
 White ref ref ref
 Black 1.61 (1.40–1.86) 1.79 (1.48–2.16) 1.48 (1.26–1.75)
 Otherb 1.10 (0.97–1.25) 1.20 (1.00–1.44) 1.05 (0.91–1.21)
Primary payer
 Private Ref Ref Ref
 Medicare 1.16 (1.07–1.26) 1.09 (0.94 -1.26) 1.20 (1.09 -1.31)
 Medicaid 1.25 (1.06–1.47) 1.17 (0.93–1.47) 1.30 (1.05–1.61)
 Otherc 0.95 (0.79–1.13) 0.91 (0.69–1.20) 0.97 (0.79–1.20)
Elective admission 1.30 (1.20–1.40) 1.24 (1.11–1.38) 1.32 (1.22–1.43)
Region
 Midwest ref ref ref
 Northeast 1.65 (1.33–2.07) 1.76 (1.39–2.28) 1.59 (1.25–2.03)
 South 1.06 (0.87–1.30) 1.09 (0.88–1.35) 1.04 (0.84–1.29)
 West 1.06 (0.88–1.27) 1.00 (0.82–1.23) 1.09 (0.89–1.33)
Hospital location/teaching
 Urban, teaching ref ref ref
 Urban, non-teaching 1.14 (0.98–1.32) 1.11 (0.94–1.32) 1.16 (0.99–1.35)
 Rural 0.60 (0.33–1.08) 0.52 (0.29–0.96) 0.65 (0.36–1.18)
Coronary artery disease 2.60 (2.43–2.77) 2.60 (2.37–2.85) 2.58 (2.37–2.81)
Ventricular arrhythmia 3.71 (3.36–4.10) 3.93 (3.38–4.56) 3.62 (3.22–4.06)
Elixhauser indexd 0.96 (0.94–0.99) 0.96 (0.93–0.99) 0.97 (0.94–1.00)
CRT response variablese
 0 0.27 (0.24–0.31) 0.16 (0.13–0.19) 0.40 (0.35–0.47)
 1–2 0.35 (0.32–0.37) 0.24 (0.21–0.27) 0.47 (0.43–0.52)
 ≥3 ref ref ref
a

2006–12.

b

Includes Hispanic, Asian or Pacific Islander, Native American, and other.

c

Includes self-pay, no charge, and other.

d

Measures 27 comorbidities of the Elixhauser index.

e

Comprised of four conditions associated with an increased likelihood of left ventricular reverse remodeling following CRT: non-ischaemic cardiomyopathy, left bundle block, absence of chronic kidney disease, and absence of atrial fibrillation.